Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/74—Synthetic polymeric materials
  • A61K31/765—Polymers containing oxygen
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/74—Synthetic polymeric materials
  • A61K31/765—Polymers containing oxygen
  • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/74—Synthetic polymeric materials
  • A61K31/785—Polymers containing nitrogen
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P3/00—Drugs for disorders of the metabolism
  • A61P3/04—Anorexiants; Antiobesity agents
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P3/00—Drugs for disorders of the metabolism
  • A61P3/06—Antihyperlipidemics

Definitions

• Anorectic agents such as dextroamphetamine, the combination of the non- amphetamine drugs phentermine and fenfiuramine ("Phen-Fen”) and dexfenfluramine (Redux) alone, are associated with serious side effects.
• Indigestible materials such as OLESTRATM, mineral oil or neopentyl esters (see U.S. Patent No. 2,962,419) have been proposed as substitutes for dietary fat.
• Garcinia acid and derivatives thereof have been described as treating obesity by interfering with fatty acid synthesis.
• Swellable crosslinked vinyl pyridine resins have been described as appetite suppressants via the mechanism of providing non- nutritive bulk, as in U.S.
• Patent 2,923,662 Surgical techniques, such as temporary ileal bypass surgery, are employed in extreme cases.
• methods for treating obesity such as those described above, have serious shortcomings with controlled diet remaining the most prevalent technique for controlling obesity. As such, new methods for treating obesity are needed.
• the present invention relates to a method for treating obesity, a method for reducing the absorption of dietary fat, and a method for treating hypertriglyceridemia in a patient and to particular polymers for use in the methods or in a manufacture of a medicament.
• the methods comprise the step of orally administering to a mammal, such as a human, a therapeutically effective amount of a fat-binding polymer.
• a fat-binding polymer of the invention facilitates the excretion of fat from the body without digestion, with minimal side effects and low toxicity.
• the fat-binding polymers are administered in combination with a therapeutically effective amount of a lipase inhibitor, such as the pancreatic lipase inhibitors described in U.S.
• the combination administration can reduce undesirable side effects often encountered when lipase inhibitors, in particular, the pancreatic lipase inhibitors lipstatin and tetrahydrolipstatin are administered alone.
• a serious side effect resulting from the administration of a lipase inhibitor is steatorrhea, or fatty stools.
• the fat-binding polymers of the invention comprise at least one fat-binding region.
• a fat-binding region can include a region having a positive charge, a region which is hydrophobic or a region having a positive charge and which is hydrophobic.
• the fat-binding polymer is an aliphatic polymer selected from the group consisting of polyalkylacrylates, polyacrylamides, polyalkylmethacrylates, polymethacrylamides, poly-N-alkylacrylamides, poly-N- alkylmethacrylamides, substituted derivatives thereof and copolymers thereof.
• the substituted derivatives of the polymers can be characterized by one or more substituents, such as substituted or unsubstituted, saturated or unsaturated alkyl, and substituted or unsubstituted aryl groups.
• Suitable substituents to employ on the alkyl or aryl groups include, but are not limited to, cationic or neutral groups, such as alkoxy, aryl, aryloxy, aralkyl, halogen, amine, and ammonium groups.
• the polymer can be poly(dimethylamino propylacrylamide), poly(trimethylammonium ethylacrylate), poly(trimethylammonium ethyl methacrylate), poly(trimethylammonium propyl acrylamide), poly(dodecyl acrylate), poly(octadecyl acrylate), poly(octadecyl methacrylate) and copolymers thereof.
• the fat binding polymer is a synthetic amine polymer.
• Amine polymers suitable for use in the invention include, but are not limited to, poly(allylamine), polyethyleneimine, poly(vinylamine), poly(diallylamine), and poly(diallylmethylamine).
• the fat-binding polymer is a hydroxyl- containing polymer, for example, poly(vinylalcohol).
• the fat-binding polymer is an amine-containing polymer wherein one or more hydrophobic regions are bound to a portion of the amine nitrogens of the amine polymer. In a particular embodiment, between about 1 and about 60 percent of the amine nitrogens are substituted, preferably between about 1 and about 30 percent.
• the hydrophobic region of the fat-binding polymer can include a hydrophobic moiety, for example, a substituted or unsubstituted, normal, branched or cyclic alkyl group having at least four carbons.
• the hydrophobic moiety is an alkyl group of between about four and thirty carbons.
• the hydrophobic region is a quaternary amine- containing moiety having a terminal hydrophobic substituent. Suitable hydrophobic regions which can include a hydrophobic moiety and/or a quaternary amine- containing moiety are described herein and in U.S. Patent Nos. 5,607,669, 5,679,717 and 5,618,530, the entire contents of which are incorporated herein by reference in their entirety.
• the fat-binding polymer is substituted by a lipase inhibitor such as those described in U.S.S.N. 09/005,379 filed on January 9, 1998, and U.S.S. N. 09/166,510 filed on October 5, 1998, the entire contents of which are incorporated herein by reference.
• the polymers of the present invention offer desirable pharmacological properties such as excellent fat binding properties and low toxicity.
• undesirable side effects experienced, such as steatorrhea, when the lipase inhibitors are administered alone can be lessened.
• the invention relates to a method for treating obesity comprising the step of orally administering to a mammal a therapeutically effective amount of one or more fat-binding polymers.
• the fat- binding polymer is administered in combination with a therapeutically effective amount of a lipase inhibitor.
• the invention relates to a method for reducing the absorption of dietary fat comprising the step of orally administering to a mammal a therapeutically effective amount of one or more fat-binding polymers.
• the fat-binding polymer is administered in combination with a therapeutically effective amount of a lipase inhibitor.
• the invention relates to a method for treating hypertriglyceridemia in a mammal comprising the step of orally administering to a mammal a therapeutically effective amount of one or more fat-binding polymers.
• the fat-binding polymer is admimstered in combination with a therapeutically effective amount of a lipase inhibitor.
• a particular aspect of the invention relates to a method for treating steatorrhea comprising the step of orally administering to a mammal a therapeutically effective amount of a fat-binding polymer.
• the steatorrhea is a result of the administration of a lipase inhibitor.
• the invention also relates to fat-binding polymers useful in the method of the invention.
• "Lipases" as that term is used herein, are ubiquitous enzymes which hydro lyze ester bonds in neutral lipids.
• lipases include, but are not limited to, pancreatic and gastric lipases.
• the preferred substrates of lipases are insoluble in water. Lipases exhibit maximal activity in the presence of lipid water interfaces. For example, pancreatic lipase, which is the key enzyme of dietary triglyceride absorption, exerts it activity at the water/lipid interface, in conjunction with bile salts and co-lipase.
• Lippase inhibitor refers to compounds which are capable of inhibiting the action of lipases, for example, gastric and pancreatic lipases.
• Lipstatin and its tetrahydro derivative, Tetrahydrolipstatin as described in U.S. Patent No. 4,598,089 to Hadvary et al., the entire content of which is hereby incorporated by reference, are potent inhibitors of both gastric and pancreatic lipases, as well as cholesterol ester hydrolase.
• Lipstatin is a natural product of microbial origin, and tetrahydrolipstatin is the result of catalytic hydrogenation of lipstatin.
• Other lipase inhibitors include a class of compound commonly referred to as Panclicins.
• Panclicins are analogues of Tetrahydrolipstatin (See e.g., Mutoh, M., et al., "Panclicins, Novel Pancreatic Lipase Inhibitors, II. Structural Elucidation/' The Journal of Antibiotics, 47(12): 1376-1384 (1994), the entire content of which is hereby incorporated by reference.)
• "Fat-binding polymers” are polymers which absorb, bind or otherwise associate with fat thereby inhibiting (partially or completely) fat digestion, hydrolysis, or absorption in the gastrointestinal tract and/or facilitating the removal of fat from the body prior to digestion.
• the fat- binding polymers comprise one or more fat-binding regions.
• “Fat-binding regions”, as defined herein can include a positively charged region, a hydrophobic region, or a region which is both positively charged and hydrophobic.
• Fats are solids or liquid oils generally consisting of glycerol esters of fatty acids.
• Sources of fats include both animal and vegetable fats, for example, triglyceride esters of saturated and/or unsaturated fatty acids, free fatty acids, diglycerides, monoglycerides, phospholipids and cholesterol esters are fats, as defined herein.
• a variety of polymers can be employed in the invention described herein. The polymers are synthetic polymers which can be aliphatic, or aromatic. However, aliphatic and synthetic polymers are preferred.
• a "synthetic polymer”, as that term is employed herein, is a polymer which is not obtainable from a natural source either directly or through a minor derivatization of the naturally occurring form. Further, the polymer can be hydrophobic, hydrophilic or copolymers of hydrophobic and/or hydrophilic monomers. The polymers can be manufactured from olefmic or ethylenic monomers (such as vinylalcohol, allylamine or acrylic acid) or condensation polymers.
• the polymers can include polyvinylalcohol, polyvinylamine, poly-N-alkylvinylamine, polyallylamine, poly-N-alkylallylamine, polydiallylamine, poly-N-alkyldiallylamine, polyalkylenimine, other polyamines, polyethers, polyamides, polyacrylic acids, polyalkylacrylates, polyacrylamides, polymethacrylic acids, polyalkylmethacrylates, polymethacrylamides, poly-N-alkylacrylamides, poly-N-alkylmethacrylamides, polystyrene, polyvinylnaphthalene, polyethylvinylbenzene, polyaminostyrene, polyvinylbiphenyl, polyvinylanisole, polyvinylimidazolyl, polyvinylpyridinyl, polydimethylaminomethylstyrene, polytrimethylammonium ethyl methacrylate,
• the polymers can be further characterized by one or more substituents such as substituents, such as substituted and unsubstituted, saturated or unsaturated alkyl, and substituted or unsubstituted aryl groups.
• substituents such as substituted and unsubstituted, saturated or unsaturated alkyl, and substituted or unsubstituted aryl groups.
• Suitable groups to employ include cationic or neutral groups, such as alkoxy, aryl, aryloxy, aralkyl, halogen, amine, and ammonium groups.
• Particularly preferred polymers include polyalkylacrylates, polyacrylamides, polyalkylmethacrylates, polymethacrylamides, poly-N-alkylacrylamides, poly-N- alkylmethacrylamides and copolymers thereof.
• These polymers can be further characterized by one or more substituents, such as substituted or unsubstituted, saturated or unsaturated alkyl, and substituted or unsubstituted aryl groups.
• substituents include cationic or neutral groups, such as alkoxy, aryl, aryloxy, aralkyl, halogen, amine, and ammonium groups, for example.
• Other particularly preferred polymers include aliphatic amine polymers, such as polyallylamine, polydiallylamine, polydiallylmethylamine, polyvinylamine, polyethylenimine.
• the amine polymer comprises one or more hydrophobic regions which are bound to a portion of the amine nitrogens of the amine polymer. In a particular embodiment, between about 1 and about 60 percent of the amine nitrogens are substituted, preferably between about 1 and about 30 percent.
• the hydrophobic region of the fat-binding polymer can include a hydrophobic moiety, for example, a substituted or unsubstituted, normal, branched or cyclic alkyl group having at least four carbons.
• the hydrophobic moiety is an alkyl group of between about four and thirty carbons.
• the hydrophobic region is a quaternary amine- containing moiety having a terminal hydrophobic substituent.
• the fat-binding region comprises a nitrogen, for example, the nitrogen of an amine, capable of possessing a positive charge under conditions present in the gastro-intestinal tract.
• a quaternary amine- containing moiety, or the nitrogen of a poly amine for example, a quaternary amine- containing moiety, or the nitrogen of a poly amine.
• the fat-binding polymer is a hydroxyl-containing polymer, for example, poly(vinylalcohol) which can comprise further fat-binding regions.
• the polymer comprises a repeat unit having the formula
• R is a hydrophobic region
• the polymer can be linear or crosslinked.
• Crosslinking can be performed by reacting the copolymer with one or more crosslinking agents having two or more functional groups, such as electrophilic groups, which react with, for example, amine groups to form a covalent bond.
• Crosslinking in this case can occur, for example, via nucleophilic attack of the polymer amino groups on the electrophilic groups. This results in the formation of a bridging unit which links two or more amino nitrogen atoms from different polymer strands.
• Suitable crosslinking agents of this type include compounds having two or more groups selected from among acyl chloride, epoxide, and alkyl-X, wherein X is a suitable leaving group, such as a halo, tosyl or mesyl group.
• X is a suitable leaving group, such as a halo, tosyl or mesyl group.
• Examples of such compounds include, but are not limited to, epichlorohydrin, succinyl dichloride, acryloyl chloride, butanedioldiglycidyl ether, ethanedioldiglycidyl ether, pyromellitic dianhydride, and dihaloalkanes.
• These crosslinking agents are referred to herein as multifunctional crosslinking agents.
• the polymer composition can also be crosslinked by including a multifunctional co-monomer as the crosslinking agent in the polymerization reaction mixture.
• a multifunctional co-monomer can be incorporated into two or more growing polymer chains, thereby crosslinking the chains.
• Suitable multifunctional co-monomers include, but are not limited to, diacrylates, triacrylates, and tetraacrylates, dimethacrylates, diacrylamides, and dimethacrylamides.
• ethylene glycol diacrylate propylene glycol diacrylate, butylene glycol diacrylate, ethylene glycol dimethacrylate, butylene glycol dimethacrylate, methylene bis(methacrylamide), ethylene bis(acrylamide), ethylene bis(methacrylamide), ethylidene bis(acrylamide), ethylidene bis(methacrylamide), pentaerythritol tetraacrylate, trimethylolpropane triacrylate, bisphenol A dimethacrylate, and bisphenol A diacrylate.
• suitable multifunctional monomers include polyvinylarenes, such as divinylbenzene.
• the amount of cross-linking agent is typically between about 0.5 and about 25 weight % based on the combined weight of crosslinking agent and monomers, with 1-20% being preferred.
• the amount of cross-linking agent that is reacted with the polymer, when the crosslinking agent is a multifunctional agent is sufficient to cause between about 0.1 and 20 percent of the nucleophiles present on the monomer, for example, an amine to react with the crosslinking agent. In a preferred embodiment, between about 3 and 15 percent of the nucleophilic sites, for example, amines react with the multifunctional crosslinking agent.
• the hydrophobic region or regions of the fat-binding polymers include but are not limited to, for example, a hydrophobic moiety such as a substituted or unsubstituted, normal, branched or cyclic alkyl group having at least about four carbons.
• a hydrophobic moiety such as an alkyl group of at least four carbons can be bound to the fat-binding polymer, for example, through an amine of the fat-binding polymer.
• a "hydrophobic moiety" is a moiety which, as a separate entity, is more soluble in octanol than water.
• the octyl group (C 8 H 17 ) is hydrophobic because its parent alkane, octane, has greater solubility in octanol than in water.
• the hydrophobic moieties can be a saturated or unsaturated, substituted or unsubstituted hydrocarbon group.
• Such groups include substituted and unsubstituted, normal, branched or cyclic alkyl groups having at least four carbon atoms, substituted or unsubstituted arylalkyl or heteroarylalkyl groups and substituted or unsubstituted aryl or heteroaryl groups.
• the hydrophobic moiety includes an alkyl group of between about four and thirty carbons.
• hydrophobic moieties include the following alkyl groups n- hexyl, n-heptyl, n-octyl, n-nonyl, n-decyl, n-undecyl, n-dodecyl, n-tetradecyl, n- octadecyl, 2-ethylhexyl, 3-propyl-6-methyl decyl and combinations thereof.
• Suitable hydrophobic moieties include haloalkyl groups of at least six carbons (e.g., 10-halodecyl), hydroxyalkyl groups of at least six carbons (e.g., 11- hydroxyundecyl), and aralkyl groups (e.g., benzyl).
• the positively charged region or regions of the fat-binding polymers include but are not limited to, for example, an amine nitrogen capable of possessing a positive charge under conditions present in the gastro-intestinal tract and a quaternary amine-containing moiety.
• Suitable quaternary amine-containing moieties include alkyl trialkylammonium groups also referred to as ammonioalkyl groups.
• ammonioalkyl refers to an alkyl group which is substituted by a nitrogen bearing three additional substituents.
• the nitrogen atom is an ammonium nitrogen atom which bears an alkylene substituent, which links the ammonium nitrogen atom to the polymer, and three additional terminal alkyl substituents having from about one to about twenty-four carbons.
• a "terminal substituent" of the quaternary amine-containing moiety, as the term is employed herein, is any one of the three substituents on the quaternary amine nitrogen which is not the carbon chain between the polymer backbone and the nitrogen of the quaternary ammonium center.
• the polymer is an amine polymer and the alkylene group links the ammonium nitrogen atom to the nitrogen atom of the polymer. It is to be understood that multiple moieties can be bound to the same amine and/or different amines of the polymer composition.
• the quaternary amine-containing moiety can bear at least one terminal hydrophobic alkyl substituent, such as an alkyl group having between about four and twenty-four carbons, thereby providing both a hydrophobic region and a positively charged region in combination.
• An ammonioalkyl group will further include a negatively charged counterion, such as a conjugate base of a pharmaceutically acceptable acid.
• Suitable counterions include Cl “ , PO 4 ⁇ Br “ , CH 3 SO 3 “ , HSO 4 “ , SO 4 2 ⁇ HCO 3 “ , CO 3 2” , acetate, lactate, succinate, propionate, butyrate, ascorbate, citrate, maleate, folate, an amino acid derivative, and a nucleotide.
• Suitable ammonioalkyl groups are of the general formula: R 1
• R 1 , R 2 and R 3 represent an alkyl group, wherein each R'-R 3 , independently, is a normal or branched, substituted or unsubstituted alkyl group having a carbon atom chain length of between about one to about twenty-four carbon atoms, n is an integer having a value of two or more and Y is a negatively charged counterion.
• R 1 , R 2 and R 3 are all methyl groups and n is an integer between about 2 and about 12 (e.g., 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, or 12).
• the alkyl group which provides the alkylene linking group between the polymer, for example, and the amine of the amine-containing monomer or repeat unit, and the ammonium nitrogen of the alkyl trialkylammonium group, is two or more carbon atoms in length.
• Examples of preferred alkylene linking groups are ethyl, propyl, butyl, pentyl, hexyl, octyl, and decyl groups.
• Example of suitable quaternary amine-containing moieties include, but are not limited to: 3-(trimethylan ⁇ monio)propyl; 4-(trimethylammonio)butyl; 6-(trimethylammonio)hexyl; 8-(trimethylammonio)octyl; 10-(trimethylammonio)decyl; 12-(trimethylammonio)dodecyl and combinations thereof.
• a particularly preferred amine-containing moiety is a 6-(trimethylammonio)hexyl group.
• quaternary amine-containing moiety and a hydrophobic moiety are present in the same substituent, thereby providing both a positively charged and hydrophobic region in combination.
• the quaternary amine nitrogen or ammonium nitrogen of the quaternary amine-containing moiety is bound to the polymer backbone by an alkylene having two or more carbons.
• at least one of the three terminal substituents (R 1 , R 2 and R 3 ) of the ammonium nitrogen is a hydrophobic alkyl group having from four to about twenty- four carbons.
• the remaining terminal substituents are each independently a normal or branched, substituted or unsubstituted alkyl group having from one to about twenty- four carbons or a hydrogen atom.
• at least two of the three terminal substituents can be hydrophobic alkyl groups having from four to about twenty-four carbons, the remainder having from one to about twenty-four carbons or a hydrogen atom.
• all three of the terminal substituents can be hydrophobic alkyl groups having from six to about twenty- four carbons.
• hydrophobic alkyl group includes a substituted or unsubstituted alkyl group having from four to about twenty- four carbons and which is hydrophobic, as earlier defined.
• the hydrophobic alkyl group can be, for example, a normal or branched, substituted or unsubstituted alkyl group having from six to about twenty-four carbons.
• quaternary amine-containing moieties which provide both a hydrophobic and quaternary amine-containing substituent, include, but are not limited to:
• quaternary amine-containing moieties include secondary and tertiary analogs, such as 4-(dioctylmethylammonio)4-methylbutyl and 4-
• the fat-binding polymers of the invention can be formed, for example, by reacting a polymer, which can be linear or crosslinked, with a suitable alkylating agent or by polymerizing an alkylated monomer.
• An "acylating agent" means a reactant that, when reacted with a monomer or a copolymer characterized by a repeat unit of the invention and having a nucleophilic site capable of reaction with the acylating agent, causes an acyl substituent, in particular a hydrophobic acyl substituent, as described herein, to be covalently bound to one or more of sites on the fat-binding polymer, for example, the amine nitrogen atoms or hydroxyl oxygens of an amine- containing or hydroxyl-containing monomer or polymer, respectively.
• substituents when multiple substituents are employed, they can be bound to the same and/or different nucleophilic sites of the fat-binding polymer, for example, the same and/or different amine nitrogens of an amine-containing fat-binding polymer or hydroxyl oxygen of a hydroxyl-containing polymer.
• Suitable acylating agents are compounds comprising an acyl group or acyl derivative, for example an anhydride .
• the acylating agent is acetic anhydride the nucleophile is modified by addition of an acetyl group.
• Acylating agents suitable for the addition of a hydrophobic moiety contain an acyl group having at least four carbon atoms, which is bonded to a leaving group such as a halo (e.g., chloro, bromo or iodo).
• Activated esters are also suitable acylating agents.
• alkylating agent means a reactant that, when reacted with a monomer or a copolymer characterized by a repeat unit of the invention and having a nucleophilic site capable of reaction with the alkylating agent, causes a hydrophobic substituent, as described herein, to be covalently bound to one or more of sites on the fat-binding polymer, for example, the amine nitrogen atoms or hydroxyl oxygens of an amine-containing or hydroxyl-containing monomer or polymer, respectively.
• Suitable alkylating agents are compounds comprising an alkyl group or alkyl derivative, having at least four carbon atoms, which is bonded to a leaving group such as a halo (e.g., chloro, bromo or iodo), tosylate, mesylate or epoxy group).
• a halo e.g., chloro, bromo or iodo
• alkyl halides having at least four carbon atoms such as n-hexyl halide, n- heptyl halide, n-octyl halide, n-nonyl halide, n-decyl halide, n-undecyl halide, n- dodecyl halide, n-tetradecyl
• a dihaloalkane that includes an alkyl group of at least four carbons (e.g., a 1,10-dihalodecane); a hydroxyalkyl halide having at least four carbon atoms (e.g., an 11-halo-l-undecanol); an aralkyl halide (e.g., a benzyl halide); an alkyl epoxy ammonium salt having at least six carbons (e.g., glycidylpropyl-trimethylammonium salts) and epoxyalkylamides having at least six carbons (e.g., N-(2,3-epoxypropyl) butyramide or N-(2,3-epoxypropyl) hexanamide).
• a dihaloalkane that includes an alkyl group of at least four carbons (e.g., a 1,10-dihalodecane); a hydroxyalkyl halide having at least four
• Preferred halogen components of the alkyl halides are bromine and chlorine.
• Particularly preferred alkylating agents which, when reacted with the polymer composition, will cause formation of an amine polymer reaction product that includes a first substituent are 1-bromodecane and 1-chlorooctane.
• suitable alkylating agents which can provide a quaternary amine-containing moiety have the general formula:
• R 1 , R 2 , and R 3 represent an alkyl group, wherein each R independently is a normal or branched, substituted or unsubstituted alkyl group having a carbon atom chain length of between about one to about twenty four carbon atoms, n is an integer having a value of two or more,
• X is a leaving group as earlier described, and Y is a negatively charged counterion.
• the alkylating agent When at least one of the three terminal substituents of the quaternary amine alkylating agent is a hydrophobic alkyl group having from four to about twenty- four carbons, the alkylating agent therefore provides both a hydrophobic moiety and a quaternary amine-containing moiety.
• the alkylene group in this instance is three or more carbon atoms in length.
• Particular examples of quaternary ammonium compounds suitable as alkylating agents include the following: (4-bromobutyl)dioctylmethylammonium bromide; (3-bromopropyl)dodecyldimethylammonium bromide;
• alkylating agents include secondary and tertiary analogs, such as (3-bromobutyl)dioctylmethylammonium bromide and (3-chloro-3,3-dimethyl propyl)dioctylmethylammonium bromide.
• alkyl trimethylammonium alkylating agents examples include alkyl halide trimethylammonium salts, such as:
• a particularly preferred quaternary amine-containing alkylating agent is (6-bromohexyl)- trimethylammonium bromide.
• the fat-binding polymer can be have a lipase inhibitor covalently bound to the polymer as described in U.S.S.N. 09/005,379 filed on January 9, 1998, and U.S.S.N. 09/166,510 filed on October 5, 1998, the entire contents of both of which are incorporated herein by reference.
• the fat-binding polymer can be administered in combination with a lipase inhibitor which is convalently bound to a polymer as described in U.S.S.N. 09/005,379 filed on January 9, 1998, and U.S.S.N. 09/166,510 filed on October 5, 1998, the entire contents of which are incorporated herein by reference.
• the terms “therapeutically effective amount” and “therapeutic amount” are synonymous.
• the terms refer to an amount which is sufficient to treat obesity, reduce the absorption of fat, facilitate the removal of fat prior to digestion or treat hypertriglyceridemia.
• the dosage of fat-binding polymer administered to the patient will vary depending among other things on the weight of the patient and the general health of the patient. The dosage can be determined with regard to established medical practice.
• the amount of fat-binding polymer administered can be in the range of from about
• the amount of lipase inhibitor which can be administered in combination with the fat-binding polymers of the invention can be determined with regard to accepted medical practice.
• the fat-binding polymer is administered in combination with a lipase inhibitor, as described herein.
• the term "in combination" in this context includes both simultaneous or sequential administration (either type of compound first) of the fat-binding polymer and lipase inhibitor.
• the fat-binding polymer and lipase inhibitor when used in combination, can be employed together in the same dosage form or in separate dosage forms taken at the same time or within a time period, wherein both the fat-binding polymer and lipase inhibitor are present in a therapeutically effective amount.
• the fat-binding polymers of the invention can be formulated using conventional inert pharmaceutical adjuvant materials into dosage forms which are suitable for oral administration.
• the oral dosage forms include tablets, capsules, suspension, solutions, and the like.
• the identity of the inert adjuvant materials which are used in formulating the fat-binding polymers of the invention will be immediately apparent to persons skilled in the art.
• These adjuvant materials include, for example, gelatin, albumin, lactose, starch, magnesium stearate, preservatives (stabilizers), melting agents, emulsifying agents, salts, and buffers.
• preservatives stabilizers
• melting agents melting agents
• emulsifying agents salts, and buffers.
• DAA Diallylamine
• This mixture was stirred at room temperature (19-22°C) until a gel formed (approx. 30 min), then stirring was suspended and the mixture was allowed to sit at room temperature for 20 hours. After the 20 hour reaction time had elapsed, the gel was transferred into a 5 -liter bucket with 3 liters of deionized water. The mixture was then stirred with an overhead mechanical stirrer until the gel was well dispersed in solution. The pH was then adjusted to ⁇ 1 using concentrated HC1. The mixture was then vacuum filtered through Whatman 541 filter paper. The filtered polymer gel was then collected and purified by suspension into 4 liters of deionized water followed by vacuum filtration through Whatman 541 filter paper.
• EXAMPLE 14 LOW LEVEL CROSSLINKING OF A SOLUBLE POLYMER TO OBTAIN A HIGH MOLECULAR WEIGHT
• the pH was adjusted to 11.5 - 12.0 by the addition of a 50% NaOH solution.
• the reaction mixture was then poured into a 5-liter beaker containing 2 liters of methanol stirred with an overhead mechanical stirrer. A fine precipitate was observed as this mixture was stirred for 30 minutes.
• the mixture was vacuum filtered through Whatman 541 filter paper, and the clear filtrate was acidified with concentrated HC1 (pH ⁇ 1) producing a thick polymer precipitate and a cloudy solution.
• the cloudy methanol solution was decanted away from the crude solid product.
• the precipitate was dissolved in a minimum amount of water (approx. 300 mL) and acidified with concentrated HC1 to a pH of ⁇ 2.
• the aqueous polymer solution was then poured with overhead mechanical stirring into a 3-liter beaker containing at least 5 volumes (approx. 1.5 liters) of methanol (Isopropanol can be used in place of methanol in this step).
• methanol Isopropanol can be used in place of methanol in this step.
• the polymeric product precipitated as a white solid.
• the precipitate was separated from solution by decantation and suspended in 2 liters of isopropyl alcohol.
• the solid was broken up using a metal spatula and the mixture was stirred for 2 hours.
• the isopropyl alcohol was then removed by decanting and the product was again suspended in 2 liters of fresh isopropyl alcohol.
• the clear filtrate was acidified with concentrated HC1 to a pH of ⁇ 2, and the polymer product was precipitated with the addition of a large volume of ethanol.
• the solid was collected by decantation and washed with isopropanol.
• the solid product was then placed in a convection oven at 70 °C to dry (24 - 48 hours).
• the dried solid was ground to a fine powder using a lab mill with stainless steel blades, and was passed through a sieve (50 mesh) to remove large granules.
• EXAMPLE 16 ALKYLATION OF AN INSOLUBLE GEL
• the mixture was then heated to 70 °C, and the pH of the solution was brought to 10.0 - 10.2 by the addition of NaOH (50% solution).
• 1-Bromododecane (26.17 g, 0.105 mol) was then added to the stirred solution in one portion. This mixture was stirred at 70 °C for 20 hours. The solution pH was checked periodically during this time, and was maintained at 10.0 - 10.2 by the addition of small quantities of 50% NaOH. After the 20 hour reaction time had elapsed, the mixture was cooled to room temperature and the pH was adjusted to ⁇ 1 using concentrated HC1. The reaction mixture was then poured into a 5-liter beaker containing 3 liters of methanol stirred with an overhead mechanical stirrer.
• the mixture was stirred until a uniform suspension resulted.
• the mixture was then vacuum filtered through Whatman 541 filter paper.
• the filtered polymer gel was collected and suspended in 3 liters of fresh methanol.
• the methanol suspension was acidified to a pH of ⁇ 1 with concentrated HC1.
• the mixture was then vacuum filtered through Whatman 541 filter paper.
• the filtered polymer gel was collected and suspended in 4-liters of 2M aqueous NaCl.
• the aqueous suspension was acidified to a pH of ⁇ 1 with concentrated HC1.
• the mixture was then vacuum filtered through Whatman 541 filter paper.
• the filtered polymer gel was then collected and purified by suspension into 4 liters of deionized water followed by vacuum filtration through Whatman 541 filter paper.
• the mixture was then cooled to 15°C with an ice bath, and the pH of the solution was brought to 9.5 by the addition of NaOH (50% solution).
• Acetic anhydride (15.41 g, 0.151 mol) was then added to the stirred solution in one portion. This mixture was stirred at 15 °C for 30 minutes. The solution pH was maintained at 9.5 during this time by the addition of small quantities of 50% NaOH. After the 30 minutes it was observed that the pH of the mixture was stable.
• the crude polymer product was then purified by suspension into 4 liters of deionized water followed by vacuum filtration through Whatman 541 filter paper. The procedure of suspension into deionized water followed by vacuum filtration was repeated several times until the conductivity of the suspended polymer gel was ⁇ 1 mS/cm.
• EXAMPLE 82 ALKYLATION OF A SOLUBLE POLYMER
• the mixture was cooled to room temperature and the pH was adjusted to 11.5 - 12.0 by the addition of a 50% NaOH solution.
• the reaction mixture was then poured into a 5-liter beaker containing 2 liters of methanol stirred with an overhead mechanical stirrer. A fine precipitate was observed as this mixture was stirred for 30 minutes.
• the mixture was vacuum filtered through Whatman 541 filter paper, and the clear filtrate was acidified with concentrated HC1 (pH ⁇ 1) producing a thick polymer precipitate and a cloudy solution.
• the cloudy methanol solution was decanted away from the crude solid product.
• the precipitate was dissolved in a minimum amount of water (approx.
• Example 82 10 MOL% HEXYL-POLY(ALLYLAMINE) HCL
• the procedure of Example 82 was used.
• the 50% aqueous solution of poly(allylamine)HCl was replaced with an equivalent amount of a 50% aqueous solution of the polymer product of Example 14.
• 1-bromohexane 17.66 g, 0.107 mol
• EXAMPLE 84 PREPARATION OF 0.75 MOL% CROSSLINKED, 10 MOL% DODEC YL-POLY(ALL YLAMINE) HCL
• Example 82 The procedure of Example 82 was used. The 50% aqueous solution of poly(allylamine)HCl was replaced with an equivalent amount of a 50% aqueous solution of the polymer product of Example 14.
• EXAMPLE 85 PREPARATION OF 0.75 MOL% CROSSLINKED, 2 MOL% OCTADECYL-POLY(ALLYLAMINE) HCL
• Example 82 The procedure of Example 82 was used. The 50% aqueous solution of poly(allylamine)HCl was replaced with an equivalent amount of a 50% aqueous solution of the polymer product of Example 14. In place of the 1 -bromododecane, 1 -bromooctadecane (7.13 g, 0.021 mol) was used.
• Example 82 25 MOL% DODECYL-POLY(ALLYLAMLNE)HCL The procedure of Example 82 was used. The amount of dodecyl bromide used was 67.3 g, 0.27 mol. The 50% aqueous solution of poly(allylamine)HCl was replaced with an equivalent amount of a 50% aqueous solution of the polymer product of Example 14.
• EXAMPLE 87 PREPARATION OF 25 MOL% HEXYL-
• the solution pH was checked periodically during this time, and was maintained at 10.0 - 10.2 by the addition of small quantities of 50% NaOH. After the 20 hour reaction time had elapsed, the mixture was cooled to room temperature and the pH was adjusted to 11.5 - 12.0 by the addition of a 50% NaOH solution. The reaction mixture was then poured into a 5-liter beaker containing 2 liters of methanol stirred with an overhead mechanical stirrer. A fine precipitate was observed as this mixture was stirred for 30 minutes. The mixture was vacuum filtered through Whatman 541 filter paper, and the clear filtrate was acidified with concentrated HC1 (pH ⁇ 1) producing a thick polymer precipitate and a cloudy solution. The cloudy methanol solution was decanted away from the crude solid product.
• Polyethylenimine 200 g of a 50% aqueous solution from Aldrich Chemical Co., 2.32 mol monomer equivalents was dissolved a mixture of ethanol (213 mL) and water (125 mL), and was heated to 70° C in a 1 -liter, round-bottomed flask equipped with an overhead mechanical stirrer, a condenser, and a thermocouple probe.
• 1-Bromohexane (95.7 g, 0.58 mol) was then added to the stirred solution in one portion. This mixture was stirred at 70 °C for 20 hours. The solution pH was checked periodically during this time, and was maintained at 10.0 - 10.2 by the addition of small quantities of 50% NaOH.
• the mixture was cooled to room temperature and poured into a 20-liter bucket containing 3 liters of methanol stirred with an overhead mechanical stirrer.
• the mixture was acidified with concentrated HC1 (pH ⁇ 2), but no precipitate was formed.
• Isopropanol (6 liters) was added, giving a small amount of precipitate.
• Diethyl ether was then added (3 liters) and the crude product precipitated. The solvent was decanted away from the product.
• the crude product was then redispersed in 750 mL of deionized water.
• the pH was adjusted to ⁇ 2 using concentrated HCL Acetonitrile (5 liters) was then added to precipitate the polymer.
• the solution pH was checked periodically during this time, and was maintained at 10.0 - 10.2 by the addition of small quantities of 50% NaOH. After the 20 hour reaction time had elapsed, the mixture was cooled to room temperature and poured into a 20- liter bucket containing 2 liters of methanol stirred with an overhead mechanical stirrer. The mixture was acidified with concentrated HC1 (pH ⁇ 2), resulting in the precipitation of some polymer. Isopropanol was then added (3 liters) and the crude product precipitated. The solvent was decanted away from the product. The crude product was then redispersed in water (750 mL) and methanol (400 mL) and the pH was adjusted to ⁇ 2 using concentrated HC1.
• the mixture was acidified with concentrated HC1 (pH ⁇ 2), resulting in the precipitation of some polymer.
• Isopropanol was then added (3 liters) and the crude product precipitated. The solvent was decanted away from the product.
• the crude product was then redispersed in water (750 mL) and methanol (400 mL) and the pH was adjusted to ⁇ 2 using concentrated HC1.
• Isopropanol (6 liters) was then added to precipitate the product, which was collected by decantation.
• the solid product was then placed in a convection oven at 70°C to dry (24 - 48 hours).
• the solution pH was checked periodically during this time, and was maintained at 10.0 - 10.2 by the addition of small quantities of 50% NaOH. After the 20 hour reaction time had elapsed, the mixture was cooled to room temperature and poured into a 20- liter pail containing 5 liters of ethanol stirred with an overhead mechanical stirrer. The mixture was acidified with concentrated HC1 (pH ⁇ 2), resulting in the precipitation of the crude product. The solvent was decanted, and the crude product was then redissolved in water (750 mL). The pH was adjusted to ⁇ 2 using concentrated HCL Isopropanol (6 liters) was then added to precipitate the product, which was collected by decantation.
• the solid product was then placed in a convection oven at 70 °C to dry (24 - 48 hours).
• the dried solid was ground to a fine powder using a lab mill with stainless steel blades, and was passed through a sieve (50 mesh) to remove large granules.
• the mixture was cooled to room temperature and poured into a 20- liter bucket containing 3.5 liters of methanol stirred with an overhead mechanical stirrer.
• the mixture was acidified with concentrated HC1 (pH ⁇ 2), resulting in the precipitation ofthe crude product.
• the solvent was decanted, and the crude product was then redissolved in water (1100 mL).
• the pH was adjusted to ⁇ 2 using concentrated HCL Isopropanol (6 liters) was then added to precipitate the product, which was collected by decantation.
• the solid was washed with another 2 liters of clean isopropanol and collected by decantation.
• the solid product was then placed in a convection oven at 70°C to dry (24 - 48 hours).
• the dried solid was ground to a fine powder using a lab mill with stainless steel blades, and was passed through a sieve (50 mesh) to remove large granules.
• the mixture was acidified with concentrated HC1 (pH ⁇ 2), resulting in the precipitation the crude product.
• the solvent was decanted, and the crude product was then redissolved in water (700 mL).
• the pH was adjusted to ⁇ 2 using concentrated HCL Isopropanol (6 liters) was then added to precipitate the product, which was collected by decantation.
• the solid was washed with another 2 liters of clean isopropanol and collected by decantation.
• the solid product was then placed in a convection oven at 70 °C to dry (24 - 48 hours).
• the dried solid was ground to a fine powder using a lab mill with stainless steel blades, and was passed through a sieve (50 mesh) to remove large granules.
• EXAMPLE 102 PREPARATION OF 5 MOL% DOCOS YL- POLYETHYLEN ⁇ M ⁇ NE HCL
• Example 101 The procedure of Example 101 was used. The amount of 1-bromodocosane used was 45.2 g, 0.116 mol. Yield - 160 g
• This mixture was stirred at 70 °C for 20 hours.
• the solution pH was checked periodically during this time, and was maintained at 10.0 - 10.2 by the addition of small quantities of 50% NaOH.
• the mixture was cooled to room temperature and poured into a 5- liter beaker containing 3 liters of deionized water stirred with an overhead mechanical stirrer.
• the crude polymeric product precipitated from solution and was collected by decantation.
• the crude product was added to a mixture of 300 mL deionized water and 300 mL ethanol.
• the mixture was acidified with concentrated HC1 (pH ⁇ 1) and stirred for at least 2 hours. Isopropanol (3 liters) was then added to precipitate the product.
• the solid polymer was then washed with clean isopropanol (2 liters).
• the solid product was then placed in a convection oven at 70°C to dry (24 - 48 hours).
• the dried solid was ground to a fine powder using a lab mill with stainless steel blades, and was passed through a sieve (50 mesh) to remove large granules.
• Example 104 The procedure of Example 104 was used. The amount of 1-bromohexane used was 3.72 g, 0.023 mol.
• Example 104 PREPARATION OF 25 MOL% HEXYL-
• EXAMPLE 109 PREPARATION OF 50 MOL% HEXYL-
• TMAEAC Trimethylaminoethyl acrylchloride quaternary salt
• the mixture was purged with nitrogen for 10 min before the addition of a radical initiator, AIBN ( 330 mg, 2 mmoles).
• AIBN 330 mg, 2 mmoles
• the mixture was heated to 70° C for 16 hours.
• the reaction mixture was allowed to cool to room temperature and poured into a beaker containing isopropanol ( 1 liter).
• the polymer was precipitated out as a white solid, which was collected and ground to small pieces in a blender using isopropanol as a solvent.
• the pieces were collected by filtration and the polymer was dried under vacuum at 60°C for 2 days.
• the material was ground to a fine powder (82 g), which was used for the in vitro and in vivo studies.
• the mixture was purged with nitrogen for 10 min before the addition of a radical initiator, AEBN ( 330 mg, 2 mmoles).
• AEBN a radical initiator
• the mixture was heated to 70° C for 16 hours.
• the reaction mixture was allowed to cool to room temperature and poured into a beaker containing isopropanol ( 1 liter).
• the polymer was precipitated out as a white solid, which was collected and ground to small pieces in a blender using isopropanol as a solvent.
• the pieces were collected by filtration and the polymer was dried under vacuum at 60°C for 2 days.
• the material was ground to a fine powder (80 g), which was used for the in vitro and in vivo studies.
• the polymers of Table 5 were prepared using the above procedure.
• TMAEAC trimethylaminoethyl acrylchloride quaternary salt
• reaction mixture was allowed to cool to room temperature and poured into a beaker containing isopropanol (1 liter).
• the polymer was precipitated out as a white solid, which was collected and ground to small pieces in a blender using isopropanol as a solvent. The pieces were collected by filtration and the polymer was dried under vacuum at 60°C for 2 days. The material was ground to a fine powder (80 g), which was used for the in vitro and in vivo studies.
• EXAMPLE 146 PREPARATION OF METHYLENEBISACRYLAMIDE (4 MOLE %) CROSS-LINKED POLYMERS OF
• reaction mixture was purged with nitrogen for 10 min before the addition of a radical initiator, AEBN (330 mg, 2 mmoles).
• AEBN a radical initiator
• the mixture was heated to 70° C for 16 hours.
• reaction mixture was allowed to cool to room temperature and poured into a beaker containing isopropanol (1 liter).
• the polymer was precipitated out as a white solid, which was collected and ground to small pieces in a blender using isopropanol as a solvent.
• the pieces were collected by filtration and the polymer was dried under vacuum at 60°C for 2 days.
• the material was ground to a fine powder (84 g), which was used for the in vitro and in vivo studies.
• TMAEAC trimethylaminoethyl acrylchloride quaternary salt
• the mixture was heated to 70° C for 16 hours.
• the reaction mixture was allowed to cool to room temperature and poured into a beaker containing isopropanol (1 liter).
• the polymer was precipitated out as a white solid, which was collected and ground to small pieces in a blender using isopropanol as a solvent.
• the pieces were collected by filtration and the polymer was dried under vacuum at 60°C for 2 days.
• the material was ground to a fine powder (80 g), which was used for the in vitro and in vivo studies.
• the following cross-linked polymers were prepared.
• the polymers of Table 8 were prepared using the above procedure.
• TMAEMC trimethylammonioethyl methacrylate chloride
• Nitrogen was allowed to bubble through the room temperature monomer mixture for at least 20 minutes before adding 0.275 g AEBN [2,2'-azobis(2-methyl-propionitrile)]. At this point the nitrogen was set to blanket the mixture and the heat was turned on to 70° C. The reaction was allowed to heat for 22 hours at 70 °C. While the polymer was still warm it was poured from the flask into a Nalgene bucket and allowed to stand for at least three hours in each of four 1 -liter washings of isopropanol. Once the polymer became slightly rigid rubbery it was broken up into small chunks using a blender (with isopropanol as the liquid).
• the granular product was filtered and washed with more isopropanol and placed in a crystallizing dish in a 70°C convection oven for two days. After this time, the product was removed and ground to a fine powder using a grinder and placed back in the oven for two more days.
• GPC analysis of octadecyl methacrylate containing polymers shows MW ranges form 100K-150K with polydispersities ranging from 2.5-5. The following table gives general mole percent compositions of polymers prepared in this fashion.
• TMAEMC trimethylammonioethyl methacrylate chloride
• TMAEMC trimethylammonioethyl methacrylate chloride
• dodecyl methacrylate (6.85 g, 26.96 mmol
• methacrylamide 9.18 g, 108.0 mmol
• ethanol 300 mL
• the total amount of monomer solids should be 100 g.
• Nitrogen was allowed to bubble through the room temperature monomer mixture for at least 20 minutes before adding 0.275 g AEBN [2,2'-azobis(2-methyl-propionitrile)]. At this point, the nitrogen was set to blanket the mixture and the heat was turned on to 70 °C. The reaction was allowed to heat for 22 hours at 70 °C. While the polymer was still warm it was poured from the flask into a Nalgene bucket and allowed to stand for at least three hours in each of four 1 -liter washings of isopropanol. Once the polymer became slightly rigid/rubbery it was broken up into small chunks using a blender (with isopropanol as the liquid).
• the granular product was filtered and washed with more isopropanol and placed in a crystallizing dish in a 70° C convection oven for two days. After this time, the product was removed and ground to a fine powder using a grinder and placed back in the oven for two more days.
• GPC analysis of dodecyl methacrylate containing polymers shows MW ranges form 170-190K with polydispersities ranging from 2.3-2.8. Table 10 gives general mole percent compositions of polymers prepared in this fashion.
• the polymers of Table 10 were prepared using the above procedure.
• TMAEMC trimethylammonioethyl methacrylate chloride
• Nitrogen was allowed to bubble through the room temperature monomer mixture for at least 20 minutes before adding 0.275 g AEBN [2,2'-azobis(2-methyl-propionitrile)]. At this point, the nitrogen was set to blanket the mixture and the heat was turned on to 70 °C. The reaction was allowed to heat for 22 hours at 70 °C. While the polymer was still warm it was poured from the flask into a Nalgene bucket and allowed to stand for at least three hours in each of four 1 -liter washings of isopropanol. Once the polymer became slightly rigid/rubbery it was broken up into small chunks using a blender (with isopropanol as the liquid).
• the polymers of Table 11 were prepared using the above procedure.
• EXAMPLE 200 PREPARATION OF METHACRYLATE METHYLENEBISMETHACRYLAMIDE ( 2MOLE %)
• CROSS-LINKED POLYMER OF METHACRYLAMIDE (20 MOL%)/TMAEMC (78 MOL%)/ OCTADECYL METHACRYLATE (2 MOL%) To a 1 -liter, three-necked, two-part reaction flask equipped with condenser, mechanical stirrer, water bath, and nitrogen bubbler was added trimethylammonioethyl methacrylate chloride (TMAEMC), -75% aqueous (87.19 g, 420.39 mmol) octadecyl methacrylate (3.65 g,10.80 mmol), methacrylamide (9.16 g, 107.76 mmol), and ethanol (400 mL).
• TMAEMC trimethylammonioethyl methacrylate chloride
• the total amount of monomer solids should be 100 g. To this was added an additional 2 mole percent (of total monomers) N,N'-methylenebismethacrylamide (1.96 g, 10.76 mmol). Nitrogen was allowed to bubble through the room temperature monomer mixture for at least 20 minutes before adding 0.275 g AEBN [2,2'-azobis(2-methyl- propionitrile)]. At this point, the nitrogen was set to blanket the mixture and the heat was turned on to 70° C. Once the polymer began to gel the stirring was turned off; total heating time at 70 °C was approximately 5 hours. The polymer was then allowed cool down to room temperature and stand overnight.
• the gelled product was scooped out of the flask and swollen to a clear gel in a 500 mL isopropanol/ 1000 mL water mixture.
• the gel was washed 6X with 1000 mL isopropanol filtering over a 50-mesh sieve.
• the product was filtered over a sieve, wrung out, and placed in a drying dish in a 70 °C convection oven for two days. After this time, the product was removed and ground to a fine powder using a grinder and placed back in the oven for two more days in a glass crystallizing dish.
• Table 12 gives general mole percent compositions of polymers prepared in this fashion.
• the polymers of Table 12 were prepared using the above procedure.
• BISMETHACRYLAMIDE 2MOLE %) CROSS-LINKED POLYMER OF METHACRYLAMIDE (20 MOL%)/ TMAEMC (75 MOL%)/ DODECYL METHACRYLATE (5 MOL%)
• TMAEMC trimethylammonioethyl methacrylate chloride
• TMAEMC trimethylammonioethyl methacrylate chloride
• dodecyl methacrylate (6.85 g, 26.96 mmol)
• methacrylamide 9.18g , 108.0 mmol
• ethanol 400 mL
• the total amount of monomer solids should be 100 g.
• N,N'-methylenebismethacrylamide (1.96 g, 10.79 mmol).
• Nitrogen was allowed to bubble through the room temperature monomer mixture for at least 20 minutes before adding 0.275 g AE3N [2,2'-azobis(2-methyl-propionitrile)]. At this point, the nitrogen was set to blanket the mixture and the heat was turned on to 70° C. Once the polymer began to gel the stirring was turned off; total heating time at 70 °C was approximately 5 hours. The polymer was then allowed cool down to room temperature and stand overnight. The gelled product was scooped out of the flask and swollen to a clear gel in a 500 mL isopropanol/ 1000 mL water mixture. The gel was washed 6X with 1000 mL of isopropanol filtering over a 50-mesh sieve.
• TMAEMC trimethylammonioethyl methacrylate chloride
• N,N'-methylenebismethacrylamide 1.989 g, 10.93 mmol.
• Nitrogen was allowed to bubble through the room temperature monomer mixture for at least 20 minutes before adding 0.275 g AEBN [2,2'-azobis(2-methyl-propionitrile)]. At this point, the nitrogen was set to blanket the mixture and the heat was turned on to 70° C. Once the polymer began to gel the stirring is turned off; total heating time at 70°C was approximately 5 hours. The polymer was then allowed cool down to room temperature and stand overnight.
• the gelled product was scooped out of the flask and swollen to a clear gel in a 500 mL isopropanol/ 1000 mL of water mixture.
• the gel was washed 6X with 1000 mL isopropanol filtering over a 50-mesh sieve.
• the spongy product is filtered over a sieve, pressed dry, and placed in a drying dish in a 70° C convection oven for two days. After this time the product was removed and ground to a fine powder using a grinder and placed back in the oven for two more days in a glass crystallizing dish.
• Table 14 gives general mole percent compositions of polymers prepared in this fashion.
• EMULSEFIER SOLUTION Egg yolk lecithin 2.54 mmol (2.00 g) and cholesterol 1.25 mmol (0.483 g) were dissolved in 100 mL of chloroform in a 1 -liter, round-bottomed flask and the solvent was removed rapidly using a rotary evaporator. A coating of lecithin and cholesterol resulted, adhering to the walls of the flask. This film was held under vacuum for 12 hours.
• the sodium salts of the following bile acids were then added to the flask: glycochohc 1.217 g (2.496 mmol), taurochohc 0.895 g (1.664 mmol), glycodeoxycholic 1.766 g (3.744 mmol), taurodeoxycholic 1.302 g (2.496 mmol).
• MES 2-[N-morpholino]ethanesulfonic acid
• test polymers When the physiological emulsion described above was mixed with test polymers, it was observed that a solid polymer/lipid complex would form in some cases. A test was devised to measure the quantity of lipid absorbed by the test polymers from the physiological emulsion.
• the olive oil emulsion described above (15 mL) was then added to the filter cup using an analytical pipette.
• the cap was replaced, and the centrifuge tube shaken (250 rpm) on an orbital mixer for a period of one hour.
• the centrifuge filter device was then disassembled so that the tape could be removed from the bottom of the centrifuge filter cup. It was immediately reassembled and spun in a centrifuge at an RCF of 500 G, and at 25 °C for 30 minutes.
• the centrifuge filter device was removed from the centrifuge and disassembled.
• the filter cup was weighed to obtain the weight gain of the wet polymer/lipid complex. This material was the removed from the filter cup with a spatula, and placed into a tared glass vial.
• the vial was weighed again to obtain the weight of the polymer/lipid sample.
• the vial was then placed into a centrifugal evaporator, and dried at 60 °C under vacuum until a pressure of 0.15 Torr or less was achieved (8-18 hrs).
• the vial was removed and weighed to obtain the dry weight of the polymer/lipid complex sample.
• the amount of lipid absorbed by the original 25 mg polymer sample in the filter cup was then calculated. This gravimetric result was used as a measure for lipid binding by the polymer, and is listed in the accompanying table as lipid weight absorbed (g) per gram of polymer.
• the non-crosslinked and crosslinked fat-binding polymers of Examples 5, 6, 10, 72, 173 and Chitosan were evaluated for their ability to increase the excretion of fat in the feces, relative to the control group, in normal rats over a six-day period.
• Male Sprague-Dawley rats (five to six weeks of age) were individually housed and fed ad libitum a powdered "high- fat diet," consisting of standard rodent chow supplemented with 15% lard by weight. After feeding the animals this diet for five days, the animals were weighed and sorted into the treatment or control groups (4-6 animals per group, each group having equal mean body weights).
• Rat fecal samples were collected on the final three days of the six days of drug treatment. The samples were freeze dried and ground to a fine powder. One half gram of sample was weighed and transferred to extraction cells. Samples were extracted in an accelerated solvent extractor (ASE 200 Accelerated Solvent Extractor, Dyonex Corporation, Sunnyvale, CA) with 95% ethanol, 5% water and 100 mM KOH. The sample was extracted in 17 minutes at 150°C and 1500 psi. An aliquot of extract was transferred to a test tube containing a molar excess of HCL The sample was then evaporated and reconstituted in a detergent solution consisting of 2% Triton X-1200, 1% polyoxyethylene lauryl ether and 0.9% NaCl. Fatty acids were then quantitated enzymatically with a colorimetric kit (NEFAC, Wako Chemical GmbH, Neuss, Germany).
• Table 16 contains values for fecal fat excretion as a percentage of ingested fat. Table 16: IN VIVO EFFICACY OF FAT-BI ⁇ DI ⁇ G POLYMERS
• Fecal Fat/Consumed Fat was calculated as follows: Fatty acid concentration from the enzymatic assay was expressed as mmol/mL. The mmol/mL of fatty acid was then multiplied by the number of mL of extract generated from 500 mg of sample to give the total mmol of fatty acid. The value for the total mmol of fatty acid was converted to total mg of fatty acid using the average molecular weight of medium to long chain fatty acid (270 D). The value was corrected for any dilutions made during sample workup. When results are expressed as mg/gm of feces, the total mg of fatty acids is multiplied by 2.
• results were expressed as total mg of fatty acid excreted in 24 hours, the mg/gm of feces value was multiplied by fecal weight in grams excreted in 24 hours.
• results were expressed as excreted fat as a % of that consumed in 24 hours, the total weight of fat excreted in 24 hours was divided by the weight of fatty acids consumed over 24 hours and multiplied by 100.

Landscapes

• Health & Medical Sciences (AREA)
• Pharmacology & Pharmacy (AREA)
• Veterinary Medicine (AREA)
• Public Health (AREA)
• General Health & Medical Sciences (AREA)
• Animal Behavior & Ethology (AREA)
• Chemical & Material Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Medicinal Chemistry (AREA)
• Epidemiology (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Organic Chemistry (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• General Chemical & Material Sciences (AREA)
• Obesity (AREA)
• Hematology (AREA)
• Diabetes (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Engineering & Computer Science (AREA)
• Child & Adolescent Psychology (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
• Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
• Polyesters Or Polycarbonates (AREA)
• Solid-Sorbent Or Filter-Aiding Compositions (AREA)
• Detergent Compositions (AREA)
• Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
• Medicinal Preparation (AREA)

Priority Applications (13)

Applications Claiming Priority (4)

Publications (2)

Family

ID=26673719

Family Applications (1)

Country Status (18)

Cited By (6)

Families Citing this family (2)

Family Cites Families (7)

• 1999
  • 1999-01-04 RU RU2000120918/14A patent/RU2222335C2/ru not_active IP Right Cessation
  • 1999-01-04 BR BR9907234-3A patent/BR9907234A/pt not_active Application Discontinuation
  • 1999-01-04 HU HU0100890A patent/HUP0100890A3/hu unknown
  • 1999-01-04 AT AT99900369T patent/ATE237349T1/de not_active IP Right Cessation
  • 1999-01-04 NZ NZ505294A patent/NZ505294A/xx unknown
  • 1999-01-04 IL IL137096A patent/IL137096A/en active IP Right Grant
  • 1999-01-04 PL PL343898A patent/PL193452B1/pl unknown
  • 1999-01-04 JP JP2000527238A patent/JP2002500183A/ja active Pending
  • 1999-01-04 DE DE69906928T patent/DE69906928T2/de not_active Expired - Fee Related
  • 1999-01-04 KR KR1020007007608A patent/KR100773625B1/ko not_active Expired - Fee Related
  • 1999-01-04 CA CA002318417A patent/CA2318417A1/en not_active Abandoned
  • 1999-01-04 NZ NZ523301A patent/NZ523301A/en unknown
  • 1999-01-04 ES ES99900369T patent/ES2200493T3/es not_active Expired - Lifetime
  • 1999-01-04 CN CNB998020311A patent/CN1212123C/zh not_active Expired - Fee Related
  • 1999-01-04 KR KR1020067021186A patent/KR20060111741A/ko not_active Ceased
  • 1999-01-04 WO PCT/US1999/000028 patent/WO1999034787A2/en not_active Ceased
  • 1999-01-04 EP EP99900369A patent/EP1043981B1/en not_active Expired - Lifetime
  • 1999-01-04 AU AU19505/99A patent/AU740233B2/en not_active Ceased
• 2000
  • 2000-07-06 MX MXPA00006681 patent/MX222446B/es active IP Right Grant
  • 2000-07-07 NO NO20003510A patent/NO20003510L/no not_active Application Discontinuation
• 2002
  • 2002-02-01 AU AU2002014755A patent/AU2002014755A1/xx not_active Withdrawn

Also Published As

Similar Documents

Legal Events